ABOS

Latest SEC Filings & News for ABOS

1 most recent filing and news item mentioning ABOS. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/ABOS/news?limit=20"

Pull ABOS filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Acumen Nominates Two EBD Development Candidates for Alzheimer's Treatment

Acumen Pharmaceuticals nominated ACU301 and ACU401 as development candidates combining its amyloid beta oligomer antibodies with JCR Pharmaceuticals' blood-brain barrier penetration technology. The company plans to submit an IND application in mid-2027, expanding its pipeline wit

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.